Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Wassermann

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Chest|August 15, 2001
How much incidence is enough?K Wassermann
Chest|May 1, 1978
The carotid bodies pathologic or physiologic?K Wassermann
Deutsche Medizinische Wochenschrift (1946)|May 17, 2000
[Airway stents. A skeptical plea for palliative medicine]K Wassermann
Acta Pharmacologica Et Toxicologica|February 1, 1983
Pharmacological screening of the nude mouse with respect to some neuroactive drugsK Wassermann
Critical Reviews in Toxicology|January 1, 1994
Intragenomic heterogeneity of DNA damage formation and repair: a review of cellular responses to covalent drug DNA interactionK Wassermann
Acta Pharmacologica Et Toxicologica|January 1, 1986
The effect of vitamin E and selenium on doxorubicin (Adriamycin) induced delayed toxicity in miceK Hermansen, K Wassermann
Cancer Chemotherapy and Pharmacology|January 1, 1986
Doxorubicin binds in a cooperative manner to myocardial cells. Two binding sitesK Wassermann, E Steiness
Pneumologie (Stuttgart, Germany)|April 1, 1997
[Evaluation of the validity of spiroergometric parameters in the differentiation of circulatory and ventilatory physical limitation]M Reuter, K Wassermann
Cancer Research|January 1, 1994
Ongoing activity of RNA polymerase II confers preferential repair of nitrogen mustard-induced N-alkylpurines in the hamster dihydrofolate reductase geneK Wassermann, J Damgaard
European Journal of Cancer & Clinical Oncology|March 1, 1987
Comparative responsiveness and pharmacokinetics of doxorubicin in human tumor xenograftsK Wassermann, S N Rasmussen
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Chest|August 15, 2001
How much incidence is enough?K Wassermann
Chest|May 1, 1978
The carotid bodies pathologic or physiologic?K Wassermann
Deutsche Medizinische Wochenschrift (1946)|May 17, 2000
[Airway stents. A skeptical plea for palliative medicine]K Wassermann
Acta Pharmacologica Et Toxicologica|February 1, 1983
Pharmacological screening of the nude mouse with respect to some neuroactive drugsK Wassermann
Critical Reviews in Toxicology|January 1, 1994
Intragenomic heterogeneity of DNA damage formation and repair: a review of cellular responses to covalent drug DNA interactionK Wassermann
Acta Pharmacologica Et Toxicologica|January 1, 1986
The effect of vitamin E and selenium on doxorubicin (Adriamycin) induced delayed toxicity in miceK Hermansen, K Wassermann
Cancer Chemotherapy and Pharmacology|January 1, 1986
Doxorubicin binds in a cooperative manner to myocardial cells. Two binding sitesK Wassermann, E Steiness
Pneumologie (Stuttgart, Germany)|April 1, 1997
[Evaluation of the validity of spiroergometric parameters in the differentiation of circulatory and ventilatory physical limitation]M Reuter, K Wassermann
Cancer Research|January 1, 1994
Ongoing activity of RNA polymerase II confers preferential repair of nitrogen mustard-induced N-alkylpurines in the hamster dihydrofolate reductase geneK Wassermann, J Damgaard
European Journal of Cancer & Clinical Oncology|March 1, 1987
Comparative responsiveness and pharmacokinetics of doxorubicin in human tumor xenograftsK Wassermann, S N Rasmussen
Pageof 11